President Trump met with pharmaceutical and biotechnology companies to discuss the development of vaccines and therapeutic treatments for the coronavirus. The companies discussed their progress in developing vaccines and treatments, as well as the need for funding and support from the government. The President expressed optimism about the progress being made and emphasized the importance of bringing manufacturing back to the US to ensure a domestic supply of medicines and equipment. The companies discussed the potential timeline for developing a vaccine, with estimates ranging from several months to a year or more. They also discussed the possibility of using existing antiviral drugs and monoclonal antibodies as treatments for the virus. Overall, the meeting was focused on collaboration and finding solutions to combat the coronavirus outbreak.